Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)

Frontiers in Cell and Developmental Biology

Volumn 2, Issue SEP, 2014, Pages

  Pacini, Simone ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bioreactors; Cell culture techniques; Cell isolation; Cell based therapy; Clinical applications; Mesenchymal stem cell transplantation; Mesenchymal stromal cells; Risk assessment

Indexed keywords

EID: 84937958474     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00050     Document Type: Review

References (111)

1. Alessandri, G., Pagano, S., Bez, A., Benetti, A., Pozzi, S., Iannolo, G., et al. (2004). Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet 26, 1872-1883. doi: 10.1016/S0140-6736(04)17443-6
2. Allen, T. D., and Dexter, T. M. (1983). Long term bone marrow cultures: an ultrastructural review. Scan Electron. Microsc. (Pt 4), 1851-1866
3. Allison, M. (2009). Genzyme backs Osiris, despite Prochymal flop. Nat. Biotechnol. 27, 966-967. doi: 10.1038/nbt1109-966
4. Au, P., Tam, J., Fukumura, D., and Jain, R. K. (2008). Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111, 4551-4558. doi: 10.1182/blood-2007-10-118273
5. Barachini, S., Trombi, L., Danti, S., D'Alessandro, D., Battolla, B., Legitimo, A., et al. (2009). Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine. Stem Cells Dev. 18, 293-305. doi: 10.1089/scd.2008.0017
6. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., et al. (2013). Risk of tumorigenicity in mesenchymal stromal cell-based therapies-bridging scientific observations and regulatory viewpoints. Cytotherapy 15, 753-759. doi: 10.1016/j.jcyt.2013.03.005
7. Bi, Y., Ehirchiou, D., Kilts, T. M., Inkson, C. A., Embree, M. C., Sonoyama, W., et al. (2007). Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat. Med. 10, 1219-1227. doi: 10.1038/nm1630
8. Bianco, P., Riminucci, M., Gronthos, S., and Robey, P. G. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180-192. doi: 10.1634/stemcells.19-3-180
9. Bieback, K., Hecker, A., Kocaömer, A., Lannert, H., Schallmoser, K., Strunk, D., et al. (2009). Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27, 2331-2341. doi: 10.1002/stem.139
10. Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., et al. (2014). Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol. Ther. 143, 181-196. doi: 10.1016/j.pharmthera.2014.02.013
11. Bühring, H. J., Battula, V. L., Treml, S., Schewe, B., Kanz, L., and Vogel, W. (2007). Novel markers for the prospective isolation of human MSC. Ann. N.Y. Acad. Sci. 1106, 262-271 doi: 10.1196/annals.1392.000
12. Canham, M. A., Sharov, A. A., Ko, M. S., and Brickman, J. M. (2010). Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript. PLoS Biol. 8:e1000379. doi: 10.1002/jcb.24166
13. Cao, Y., Sun, Z., Liao, L., Meng, Y., Han, Q., and Zhao, R. C. (2005). Human adipose tissue derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem. Biophys. Res. Commun. 332, 370-379. doi: 10.1016/j.bbrc.2005.04.135
14. C.E.C. (Commission of the European Communities). (1992). Guide to Good Manufacturing Practice (GMP) for Medical Products. The Rules Governing Medicinal Products in the European Community, Vol IV
15. Chen, H. T., Lee, M. J., Chen, C. H., Chuang, S. C., Chang, L. F., Ho, M. L., et al. (2012). Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J. Cell. Mol. Med. 16, 582-593. doi: 10.1111/j.1582-4934.2011.01335.x
16. Colter, D. C., Sekiya, I., and Prockop, D. J. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. U.S.A. 98, 7841-7845. doi: 10.1073/pnas.141221698
17. COM.EST (World Commission on the Ethics of Scientific Knowledge and Technology). (2005). The Precautionary Principle. Published in March 2005 by UNESCO
18. Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A., Fleury-Cappellesso, S., et al. (2007). Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia 21, 1079-1088. doi: 10.1038/sj.leu.2404621
19. Corselli, M., Chen, C. W., Sun, B., Yap, S., Rubin, J. P., and Péault, B. (2012). The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 21, 1299-1308. doi: 10.1089/scd.2011.0200
20. Crisostomo, P. R., Wang, M., Herring, C. M., Markel, T. A., Meldrum, K. K., Lillemoe, K. D., et al. (2007). Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J. Mol. Cell. Cardiol. 42, 142-149. doi: 10.1016/j.yjmcc.2006.09.016
21. da Silva Meirelles, L., Chagastelles, P. C., and Nardi, N. B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119, 2204-2211. doi: 10.1242/jcs.02932
22. Deasy, B. M., Lu, A., Tebbets, J. C., Feduska, J. M., Schugar, R. C., Pollett, J. B., et al. (2007). A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J. Cell Biol. 177, 73-86. doi: 10.1083/jcb.200612094
23. De Bari, C., Dell'Accio, F., Tylzanowski, P., and Luyten, F. P. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44, 1928-1942. doi: 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
24. Dennis, J. E., and Charbord, P. (2002). Origin and differentiation of human and murine stroma. Stem Cells 20, 205-214. doi: 10.1634/stemcells.20-3-205
25. Digirolamo, C. M., Stokes, D., Colter, D., Phinney, D. G., Class, R., and Prockop, D. J. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 107, 275-281. doi: 10.1046/j.1365-2141.1999.01715.x
26. Dimarino, A. M., Caplan, A. I., and Bonfield, T. L. (2013). Mesenchymal stem cells in tissue repair. Front. Immunol. 4:201. doi: 10.3389/fimmu.2013.00201
27. D'Ippolito, G., Howard, G. A., Roos, B. A., and Schiller, P. C. (2006). Isolation and characterization of marrow-isolated adult multilineage inducible (MIAMI) cells. Exp. Hematol. 34, 1608-1610. doi: 10.1016/j.exphem.2006.07.016
28. Doherty, M. J., Ashton, B. A., Walsh, S., Beresford, J. N., Grant, M. E., and Canfield, A. E. (1998). Vascular pericytes express osteogenic potential in vitro and in vivo. J. Bone Miner. Res. 13, 828-838. doi: 10.1359/jbmr.1998.13.5.828
29. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315-317. doi: 10.1080/14653240600855905
30. Elowitz, M. B., Levine, A. J., Siggia, E. D., and Swain, P. S. (2002). Stochastic gene expression in a single cell. Science 297, 1183-1186. doi: 10.1126/science.1070919
31. Fazzi, R., Pacini, S., Carnicelli, V., Trombi, L., Montali, M., Lazzarini, E., et al. (2011). Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway. PLoS ONE 6:e25600. doi: 10.1371/journal.pone.0025600
32. F.D.A. (US Food and Drug Administration). (1993). Application of current statutory authority to human somatic cell-therapy and gene-therapy products. Fed. Reg. 58, 53248-53251
33. Fekete, N., Rojewski, M. T., Fürst, D., Kreja, L., Ignatius, A., Dausend, J., et al. (2012). GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE 7:e43255. doi: 10.1371/journal.pone.0043255
34. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., and Frolova, G. P. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247. doi: 10.1097/00007890-196803000-00009
35. Gálvez, P., Clares, B., Hmadcha, A., Ruiz, A., and Soria, B. (2013). Development of a cell-based medicinal product: regulatory structures in the European Union. Br. Med. Bull. 105, 85-105. doi: 10.1093/bmb/lds036
36. Gang, E. J., Bosnakovski, D., Figueiredo, C. A., Visser, J. W., and Perlingeiro, R. C. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109, 1743-1751. doi: 10.1182/blood-2005-11-010504
37. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., and Dazzi, F. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821-2827. doi: 10.1182/blood-2004-09-3696
38. Glotzbach, J. P., Januszyk, M., Vial, I. N., Wong, V. W., Gelbard, A., Kalisky, T., et al. (2011). An information theoretic, microfluidic-based single cell analysis permits identification of subpopulations among putatively homogeneous stem cells. PLoS ONE 6:e21211. doi: 10.1371/journal.pone.0021211
39. Herberts, C. A., Kwa, M. S., and Hermsen, H. P. (2011). Risk factors in the development of stem cell therapy. J. Transl. Med. 22:29. doi: 10.1186/1479-5876-9-29
40. Hideki, A. (2013). 'Isolation of bone marrow stromal cells: cellular composition is technique-dependent'. in Regenerative Medicine and Tissue Engineering, ed J. A. Andrades, 37-50. doi: 10.5772/55543
41. Ho, A. D., Wagner, W., and Franke, W. (2008). Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10, 320-330. doi: 10.1080/14653240802217011
42. Hoogduijn, M. J., Betjes, M. G., and Baan, C. C. (2014). Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics? Curr. Opin. Organ Transplant. 19, 41-46. doi: 10.1097/MOT.0000000000000036
43. Horwitz, E. M., Andreef, M., and Frassoni, F. (2006). Mesenchymal stromal cells. Curr. Opin. Hematol. 13, 419-425. doi: 10.1097/01.moh.0000245697.54887.6f
44. Horwitz, E. M., Le Blanc, K., Dominici, M., et al. (2005). Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7, 393-395. doi: 10.1080/14653240500319234
45. Horwitz, E. M., Prockop, D. J., Fitzpatrick, L. A., Koo, W. W., Gordon, P. L., Neel, M., et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309-313. doi: 10.1038/6529
46. Hough, S. R., Laslett, A. L., Grimmond, S. B., Kolle, G., and Pera, M. F. (2009). A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PLoS ONE 4:e7708. doi: 10.1371/journal.pone.0007708
47. Ishige, I., Nagamura-Inoue, T., Honda, M. J., Harnprasopwat, R., Kido, M., Sugimoto, M., et al. (2009). Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int. J. Hematol. 90, 261-269. doi: 10.1007/s12185-009-0377-3
48. Keating, A. (2012). Mesenchymal stromal cells: new directions. Cell Stem Cell 10, 709-716. doi: 10.1016/j.stem.2012.05.015
49. Kuroda, Y., Wakao, S., Kitada, M., Murakami, T., Nojima, M., and Dezawa, M. (2013). Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat. Protoc. 8, 1391-1415. doi: 10.1038/nprot.2013.076
50. Kuznetsov, S. A., Krebsbach, P. H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., et al. (1997). Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335-1347. doi: 10.1359/jbmr.1997.12.9.1335
51. Laroni, A., Novi, G., Kerlero de Rosbo, N., and Uccelli, A. (2013). Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. J Neuroimmune Pharmacol. 8, 1062-1076. doi: 10.1007/s11481-013-9456-6
52. Larson, D. R., Singer, R. H., and Zenklusen, D. (2009). A single molecule view of gene expression. Trends Cell Biol. 19, 630-637. doi: 10.1016/j.tcb.2009.08.008
53. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringdén, O. (2003). HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31, 890-896. doi: 10.1016/S0301-472X(03)00110-3
54. Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G., and Kassem, M. (2008). Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies? Exp. Gerontol. 43, 1018-1023. doi: 10.1016/j.exger.2008.07.004
55. Lin, H.-H., Hwang, S.-M., Wu, S.-J., Hsu, L.-F., Liao, Y.-H., et al. (2014). The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy. PLoS ONE 9:e94395. doi: 10.1371/journal.pone.0094395
56. Liras, A. (2010). Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J. Transl. Med. 8:131. doi: 10.1186/1479-5876-8-131
57. Mabuchi, Y., Houlihan, D. D., Akazawa, C., Okano, H., and Matsuzaki, Y. (2013). Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers. Stem Cells Int. 2013:507301. doi: 10.1155/2013/507301
58. MacArthur, B. D., Sevilla, A., Lenz, M., Müller, F. J., Schuldt, B. M., Schuppert, A. A., et al. (2012). Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. Nat. Cell Biol. 14, 1139-1147. doi: 10.1038/ncb2603
59. MacArthur, B. D., and Lemischka, I. R. (2013). Statistical mechanics of pluripotency. Cell 154, 484-489. doi: 10.1016/j.cell.2013.07.024
60. Malliaras, K., Kreke, M., and Marbán, E. (2011). The stuttering progress of cell therapy for heart disease. Clin. Pharmacol. Ther. 90, 532-541. doi: 10.1038/clpt.2011.175
61. McCoy, R. J., and O'Brien, F. J. (2010). Influence of shear stress in perfusion bioreactor cultures for the development of three-dimensional bone tissue constructs: a review. Tissue Eng. Part B Rev. 16, 587-601. doi: 10.1089/ten.teb.2010.0370
62. Moignard, V., Macaulay, I. C., Swiers, G., Buettner, F., Schütte, J., Calero-Nieto, F. J., et al. (2013). Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis. Nat. Cell Biol. 15, 363-372. doi: 10.1038/ncb2709
63. Momin, E. N., Vela, G., Zaidi, H. A., and Quiñones-Hinojosa, A. (2010). The oncogenic potential of mesenchymal stem cells in the treatment of cancer: directions for future research. Curr. Immunol. Rev. 6, 137-148. doi: 10.2174/157339510791111718
64. Muguruma, Y., Yahata, T., Miyatake, H., Sato, T., Uno, T., Itoh, J., et al. (2006). Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107, 1878-1888. doi: 10.1182/blood-2005-06-2211
65. Mundra, V., Gerling, I. C., and Mahato, R. I. (2013). Mesenchymal stem cell-based therapy. Mol. Pharm. 10, 77-89. doi: 10.1021/mp3005148
66. Muraglia, A., Cancedda, R., and Quarto, R. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 113(Pt 7), 1161-1166
67. Otto, W. R., and Wright, N. A. (2011). Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair. 8, 4-20. doi: 10.1186/1755-1536-4-20
68. Ozbudak, E. M., Thattai, M., Kurtser, I., Grossman, A. D., and van Oudenaarden, A. (2002). Regulation of noise in the expression of a single gene. Nat. Genet. 31, 69-73. doi: 10.1038/ng869
69. Pacini, S., and Petrini, I. (2014). Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front. Cell Dev. Biol. 19:20. doi: 10.3389/fcell.2014.00020
70. Pevsner-Fischer, M., Levin, S., and Zipori, D. (2011). The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev. 7, 560-568. doi: 10.1007/s12015-011-9229-7
71. Phinney, D. G. (2012). Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J. Cell. Biochem. 113, 2806-2812. doi: 10.1002/jcb.24166
72. Phinney, D. G., Kopen, G., Righter, W., Webster, S., Tremain, N., and Prockop, D. J. (1999). Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J. Cell. Biochem. 75, 424-436
73. Phinney, D. G., and Prockop, D. J. (2007). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25, 2896-2902. doi: 10.1634/stemcells.2007-0637
74. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. doi: 10.1126/science.284.5411.143
75. Psaltis, P. J., Paton, S., See, F., Arthur, A., Martin, S., Itescu, S., et al. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J. Cell. Physiol. 223, 530-540. doi: 10.1002/jcp.22081
76. Raj, A., and van Oudenaarden, A. (2009). Single-molecule approaches to stochastic gene expression. Annu. Rev. Biophys. 38, 255-270. doi: 10.1146/annurev.biophys.37.032807.125928
77. Ranganath, S. H., Levy, O., Inamdar, M. S., and Karp, J. M. (2012). Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244-258. doi: 10.1016/j.stem.2012.02.005
78. Raser, J. M., and O'Shea, E. K. (2005). Noise in gene expression: origins, consequences, and control. Science 309, 2010-2013. doi: 10.1126/science.1105891
79. Ratajczak, M. Z., Zuba-Surma, E. K., Wysoczynski, M., Ratajczak, J., and Kucia, M. (2008). Very small embryonic-like stem cells: characterization, developmental origin, and biological significance. Exp. Hematol. 36, 742-751. doi: 10.1016/j.exphem.2008.03.010
80. Ringden, O., Uzunel, M., Rasmusson, I., et al. (2006). Mesenchymal stem cells for treatment of therapyresistant graft-versus-host disease. Transplantation 81, 1390-1397. doi: 10.1097/01.tp.0000214462.63943.14
81. Russell, K. C., Phinney, D. G., Lacey, M. R., Barrilleaux, B. L., Meyertholen, K. E., and O'Connor, K. C. (2010). In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28, 788-798. doi: 10.1002/stem.312
82. Russell, K. C., Tucker, H. A., Bunnell, B. A., Andreeff, M., Schober, W., Gaynor, A. S., et al. (2013). Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells. Tissue Eng. Part A 19, 2253-2266. doi: 10.1089/ten.tea.2012.0649
83. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., et al. (2007). Selfrenewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324-336. doi: 10.1016/j.cell.2007.08.025
84. Sarugaser, R., Hanoun, L., Keating, A., Stanford, W. L., and Davies, J. E. (2009). Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS ONE 4:e6498. doi: 10.1371/journal.pone.0006498
85. Schneider, C. K., Salmikangas, P., Jilma, B., Flamion, B., Todorova, L. R., Paphitou, A., Haunerova, I., et al. (2010). Challenges with advanced therapy medicinal products and how to meet them. Nat. Rev. Drug Discov. 9, 195-201. doi: 10.1038/nrd3052
86. Sengers, B. G., Dawson, J. I., and Oreffo, R. O. (2010). Characterisation of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modelling. Bone 46, 496-503. doi: 10.1016/j.bone.2009.10.002
87. Sensebé, L. (2013). Beyond genetic stability of mesenchymal stromal cells. Cytotherapy 15, 1307-1308. doi: 10.1016/j.jcyt.2013.09.001
88. Shabbir, A., Zisa, D., Suzuki, G., and Lee, T. (2009). Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am. J. Physiol. Heart Circ. Physiol. 296, H1888-H1897. doi: 10.1152/ajpheart.00186.2009
89. Sharma, R. R., Pollock, K., Hubel, A., and McKenna, D. (2014). Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54, 1418-1437. doi: 10.1111/trf.12421
90. Shoshani, O., Ravid, O., Massalha, H., Aharonov, A., Ovadya, Y., Pevsner-Fischer, M., et al. (2014). Cell isolation induces fate changes of bone marrow mesenchymal cells leading to loss or alternatively to acquisition of new differentiation potentials. Stem Cells 32, 2008-2020. doi: 10.1002/stem.1719
91. Siegel, G., Kluba, T., Hermanutz-Klein, U., Bieback, K., Northoff, H., and Schäfer, R. (2013). Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. 11:146. doi: 10.1186/1741-7015-11-146
92. Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., and Michalek, J. (2012). Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 21, 2724-5272. doi: 10.1089/scd.2011.0722
93. Tarte, K., Gaillard, J., Lataillade, J. J., Fouillard, L., Becker, M., Mossafa, H., et al. (2010). Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115, 1549-1553. doi: 10.1182/blood-2009-05-219907
94. Teles, J., Pina, C., Edén, P., Ohlsson, M., Enver, T., and Peterson, C. (2013). Transcriptional regulation of lineage commitment-a stochastic model of cell fate decisions. PLoS Comput. Biol. 9:e1003197. doi: 10.1371/journal.pcbi.1003197
95. Thirumala, S., Goebel, W. S., and Woods, E. J. (2013). Manufacturing and banking of mesenchymal stem cells. Expert Opin. Biol. Ther. 13, 673-691. doi: 10.1517/14712598.2013.763925
96. Tormin, A., Li, O., Brune, J. C., Walsh, S., Schütz, B., Ehinger, M., et al. (2011). CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117, 5067-5077. doi: 10.1182/blood-2010-08-304287
97. Torres-Padilla, M. E., and Chambers, I. (2014). Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage. Development 141, 2173-2181. doi: 10.1242/dev.102624
98. Trombi, L., Pacini, S., Montali, M., Fazzi, R., Chiellini, F., Ikehara, S., et al. (2009). Selective culture of mesodermal progenitor cells. Stem Cells Dev. 18, 1227-1234. doi: 10.1089/scd.2009.0054
99. Tyndall, A. (2011). Successes and failures of stem cell transplantation in autoimmune diseases. Hematology Am. Soc. Hematol. Educ. Program. 2011, 280-284. doi: 10.1182/asheducation-2011.1.280
100. Tyndall, A., Walker, U. A., Cope, A., Dazzi, F., De Bari, C., Fibbe, W., et al. (2007). Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res. Ther. 9, 301. doi: 10.1186/ar2103
101. Wagner, W., and Ho, A. D. (2007). Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev. 3, 239-248. doi: 10.1007/s12015-007-9001-1
102. Wang, Y., Zhang, Z., Chi, Y., Zhang, Q., Xu, F., Yang, Z., et al. (2013). Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis. 4, e950. doi: 10.1038/cddis.2013.480
103. Werts, E. D., DeGowin, R. L., Knapp, S. K., and Gibson, D. P. (1980). Characterization of marrow stromal (fibroblastoid) cells and their association with erythropoiesis. Exp. Hematol. 8, 423-433
104. W.H.O. (World Health Organization). (1997). A WHO guide to Good Manufacturing Practice (GMP). Published in 1997
105. Wu, J., and Tzanakakis, E. S. (2012). Contribution of stochastic partitioning at human embryonic stem cell division to NANOG heterogeneity. PLoS ONE 7:e50715. doi: 10.1371/journal.pone.0050715
106. Yamada, Y., Sakurada, K., Takeda, Y., Gojo, S., and Umezawa, A. (2007). Single-cell-derived mesenchymal stem cells overexpressing Csx/Nkx2.5 and GATA4 undergo the stochastic cardiomyogenic fate and behave like transient amplifying cells. Exp. Cell Res. 313, 698-706. doi: 10.1016/j.yexcr.2006.11.012
107. Yeatts, A. B., Choquette, D. T., and Fisher, J. P. (2013). Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems. Biochim. Biophys. Acta 1830, 2470-2480. doi: 10.1016/j.bbagen.2012.06.007
108. Yeatts, A. B., and Fisher, J. P. (2011). Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone 48, 171-181. doi: 10.1016/j.bone.2010.09.138
109. Ylöstalo, J., Bazhanov, N., and Prockop, D. J. (2008). Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. Exp. Hematol. 36, 1390-1402. doi: 10.1016/j.exphem.2008.05.003
110. Zhao, R. C. (2013). Essentials of mesenchymal stem cell biology and its clinical translation. Springer Sci. Bus. Media 17-32. doi: 10.1007/978-3-642-44910-9
111. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211-228. doi: 10.1089/107632701300062859